会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method for preparing acrylamide polymers
    • 制备丙烯酰胺聚合物的方法
    • US4306048A
    • 1981-12-15
    • US176031
    • 1980-08-07
    • Norimasa YoshidaYasuo OgawaRyoji HandaSusumu SekiJun HosodaNobuo KurashigeAkihisa Furuno
    • Norimasa YoshidaYasuo OgawaRyoji HandaSusumu SekiJun HosodaNobuo KurashigeAkihisa Furuno
    • C08K5/13C08F2/00C08F2/44C08F6/00C08F6/06C08F6/12C08F20/56C08K5/37C08K5/53C08L33/00C08L33/02C08L33/24C08L33/26C08L77/00C08J3/12
    • C08F6/12
    • In the production of a dried acrylamide polymer by polymerizing, in an aqueous medium, acrylamide alone or a monomer mixture comprising 50 mole % or more of acrylamide and at least one monomer copolymerizable therewith with a radical initiator, and then drying the resulting hydrous acrylamide polymer, the allowing of at least one of the following compounds [I], [II] and [III] to be present in the drying step or a step prior thereto enables the dried acrylamide polymer having a high molecular weight and a good dissolvability in water to be obtained:[I] a non-polymerizable compound having in its molecule at least one group represented by the formula, ##STR1## wherein R.sub.1 is H or an alkyl group having up to 4 carbon atoms, [II] a compound represented by the formula, R.sub.2 --S--C.sub.n H.sub.2n X wherein n is an integer of 1 to 8, R.sub.2 is an alkyl group, an aryl group or --C.sub.n H.sub.2n X, in which X is --OH, --COOH (or its salt), --CN or --CONH.sub.2, and[III] a compound represented by the formula, ##STR2## wherein R.sub.3, R.sub.4 and R.sub.5 are H, alkali metals or alkyl or aryl groups.
    • 在水性介质中单独使用丙烯酰胺或含有50摩尔%以上丙烯酰胺的单体混合物和至少一种可与其自由基引发剂共聚的单体的聚合反应生产干燥的丙烯酰胺聚合物,然后干燥得到的含水丙烯酰胺聚合物 ,允许至少一种以下化合物[I],[II]和[III]化合物存在于干燥步骤或之前的步骤中,使得干燥的丙烯酰胺聚合物具有高分子量和在水中的良好溶解性 [I]在其分子中具有至少一个由下式表示的基团的非聚合性化合物,其中R 1为H或具有至多4个碳原子的烷基,[II]表示的化合物 其中n为1〜8的整数,R 2为烷基,芳基或-C n H 2n,其中X为-OH,-COOH(或其盐),-CN或 - CONH 2和[III]由下式表示的化合物,其中R 3,R 4和R 3 5是H,碱金属或烷基或芳基。
    • 3. 发明授权
    • Modification of acrylamide polymers
    • 丙烯酰胺聚合物的改性
    • US4313863A
    • 1982-02-02
    • US211294
    • 1980-11-28
    • Ryoji HandaNorimasa YoshidaJun HosodaAkihisa Furuno
    • Ryoji HandaNorimasa YoshidaJun HosodaAkihisa Furuno
    • C08F8/00C08F8/12C08K5/06C08L33/00C08L33/24C08L33/26
    • C08F8/12Y10S524/916
    • When an alkaline substance is added to and mixed with aggregates of the mutually adhering blobs of a hydrogel of an acrylamide polymer, (1) a mixing tank in which the portion to be contacted with the hydrogel of an acrylamide polymer is made of a chromium-plated material is used, and (2) to said hydrogel aggregates is added at least one compound represented by the general formulae: ##STR1## wherein R.sub.1 is a residue obtained by removing two OH groups from a saturated dihydric alcohol having 2 to 4 carbon atoms, and R.sub.2 is a residue obtained by removing three OH groups from a saturated trihydric alcohol having 3 to 6 carbon atoms, and having an average molecular weight of 500 to 5,000, whereby the hydrolysis of the acrylamide polymer can be achieved at a high efficiency while preventing the mutual adhesion of the hydrogel aggregates and also reducing the adhesion of the aggregates to the interior surface of the mixing tank to such an extent that there is substantially no problem of adhesion.
    • 当将碱性物质加入并与丙烯酰胺聚合物的水凝胶的相互粘合的团块的混合物混合时,(1)混合罐,其中与丙烯酰胺聚合物的水凝胶接触的部分由铬 - (2)对所述水凝胶聚集体加入至少一种由以下通式表示的化合物:HO [C 3 H 6 O] n H(I)其中R 1是残基 通过从具有2〜4个碳原子的饱和二元醇中除去2个OH基而获得的R 2是通过从具有3〜6个碳原子的饱和三元醇除去3个OH基而得到的残基,平均分子量为500〜 5,000,从而可以高效率地实现丙烯酰胺聚合物的水解,同时防止水凝胶聚集体的相互粘附并且还降低聚集体到混合罐的内表面的粘附程度,使得存在s 基本上没有粘附问题。
    • 5. 发明授权
    • Method and system for posting ideas to a reconfigurable website
    • 将想法发布到可重新配置的网站的方法和系统
    • US07818194B2
    • 2010-10-19
    • US11786882
    • 2007-04-13
    • Norimasa YoshidaJustin LinLikuo LinKingsley Jeegan Joseph
    • Norimasa YoshidaJustin LinLikuo LinKingsley Jeegan Joseph
    • G06F17/00
    • G06Q30/02G06Q10/10G06Q30/0203G06Q99/00
    • A method for automatically reconfiguring a webpage is provided. The web page may include a plurality of sections, and each section may include at least one aspect related to a particular topic, such as customer support and an option for casting a vote for a topic posted. A vote may be received vote for at least one of the plurality of sections. A Total Qualitative Management Criterion (TQMC) may be determined for each section of the website. An increasing function of time may be applied to newer votes to enable relative weightings of older votes to diminish over time without requiring computing a decaying time function to determine weightings for each vote. The webpage may be reconfigured based on ranking the sections according to the TQMC for each section.
    • 提供了一种自动重新配置网页的方法。 网页可以包括多个部分,并且每个部分可以包括与特定主题相关的至少一个方面,例如客户支持和用于投放所发布的主题的投票的选项。 投票可以被接收对多个部分中的至少一个的投票。 可以为网站的每个部分确定总体定性管理标准(TQMC)。 时间的增加功能可能适用于较新的投票,以使老年票的相对权重随着时间的推移而减少,而不需要计算衰减时间函数来确定每次投票的权重。 可以基于每个部分根据TQMC对这些部分进行排序来重新配置网页。
    • 6. 发明授权
    • Agent for preventing and curing hindrance of ischemic reperfusion
    • 预防和治疗缺血再灌注障碍的药物
    • US06518250B2
    • 2003-02-11
    • US09993194
    • 2001-11-14
    • Toshikazu YoshikawaHironobu MuraseNorimasa Yoshida
    • Toshikazu YoshikawaHironobu MuraseNorimasa Yoshida
    • A61K3170
    • C07H17/065A61K31/704A61K31/7048C07H15/26Y10S514/824Y10S514/878Y10S514/925Y10S514/926
    • An agent for preventing and curing the hindrance of ischemic reperfusiton is disclosed which has as an active component thereof a chromanol glycoside represented by the following general formula: [wherein R1, R2, R3, and R4 independently denote a hydrogen atom or a lower alkyl group, R5 denotes a hydrogen atom, a lower alkyl group, or a lower acyl group, X denotes a monosaccharide residue or an oligosaccharide residue which may have a lower alkyl group or a lower acyl group substituted for the hydrogen atom of the hydroxyl group of the saccharide residue, n denotes an integer of 0-6, and m denotes an integer of 1-6]. The agent, even in a small dosage, acts safely and effectively on the affected part and allows the hindrances of ischemic reperfusion induced in heart, stomach, small intestine, liver, spleen, kidney, brain, and skin, and the hindrance induced during the transplantation of an internal organ to be prevented and cured.
    • 公开了预防和治疗缺血再灌注障碍的药剂,其作为其活性成分是由以下通式表示的色原肌糖苷:其中R1,R2,R3和R4独立地表示氢原子或低级烷基 R5表示氢原子,低级烷基或低级酰基,X表示可以具有低级烷基或低级酰基取代羟基的氢原子的单糖残基或寡糖残基 糖残基,n表示0-6的整数,m表示1-6的整数]。 即使在小剂量下,该药物对患部的安全有效地起作用,并且允许在心脏,胃,小肠,肝脏,脾脏,肾脏,脑和皮肤中诱导的缺血再灌注障碍,以及在 移植内脏器官以防止和治愈。